Published in Clin Pharmacol Ther on September 13, 1972
Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A (1998) 4.76
The isolation and identification of the urinary oxidative metabolites of metronidazole in man. J Pharmacol Exp Ther (1968) 2.43
Sexual adjustment, identification, and attitudes of patients with myelopathy. Arch Phys Med Rehabil (1966) 1.50
Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers. Antimicrob Agents Chemother (1992) 1.11
Leukopenia and thrombocytopenia secondary to clinoril therapy. Lancet (1980) 1.06
Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol (2000) 1.05
Isolation and identification of the major urinary metabolite of metronidazole. Life Sci (1967) 1.01
Suicide in two patients with a diagnosis of probable Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.00
Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab (2007) 0.99
Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers. J Clin Pharmacol (1998) 0.99
Cardiopulmonary toxicity of propellants for aerosols. J Clin Pharmacol (1975) 0.99
Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther (1978) 0.99
The medical uses of garlic--fact and fiction. Am Pharm (1982) 0.98
Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia. Diabetes (1974) 0.96
Varied appearance of AIDS-related lymphoma in the chest. Radiology (1989) 0.94
Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity. Cancer (1977) 0.89
Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen. Cancer Res (1981) 0.89
Lymphangioma in four dogs. J Am Vet Med Assoc (1978) 0.88
Phase I study of 5-azacytidine (NSC-102816) . Cancer Chemother Rep (1972) 0.88
Management of brachial plexus tumors. Arch Otolaryngol (1977) 0.87
A phase I study of emetine hydrochloride (NSC 33669) in solid tumors. Cancer (1973) 0.86
The clinical pharmacology of meperidine--comparison of routes of administration. J Clin Pharmacol (1976) 0.85
Combination phase 1-II study of imidazole carboxamide (NCS45388). Oncology (1972) 0.84
Phase II study of 5-azacytidine in solid tumors. Cancer Treat Rep (1977) 0.84
Streptozotocin therapy in 22 cancer patients. Cancer (1975) 0.83
Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Cancer Treat Rep (1976) 0.83
Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. J Clin Pharmacol (1977) 0.83
Identification of the metabolites of metronidazole in the human vagina. Wiad Parazytol (1969) 0.83
Toxicity of aerosol propellants on the respiratory and circulatory systems. I. Cardiac arrhythmia in the mouse. Toxicology (1974) 0.83
Influence of age and dietary stress on hexobarbital activity in mice. Proc Soc Exp Biol Med (1967) 0.83
Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816). Cancer Chemother Rep (1974) 0.82
Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis. J Clin Pharmacol (1985) 0.82
Peritoneal mesothelioma associated with diffuse abdominal ossification and unusual presentation. J Med Soc N J (1977) 0.81
Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. Cancer Chemother Rep (1972) 0.81
Diffusion in the various zones of the normal and the rachitic growth plate. J Bone Joint Surg Am (1980) 0.81
Clinical studies with tubercidin administered after absorption into human erythrocytes. Cancer Res (1970) 0.81
Phase II trial of vindesine in advanced neoplastic disease. Cancer Treat Rev (1980) 0.80
The characterization of substituted nitroimidazoles on paper and thin layer chromatography by colorimetric reactions. J Chromatogr (1967) 0.80
Preoperative embolization of retroperitoneal hemangiopericytomas as an aid in their removal. Cancer (1982) 0.80
Comparison of intramuscular dezocine with butorphanol and placebo in chronic cancer pain: a method to evaluate analgesia after both single and repeated doses. Clin Pharmacol Ther (1987) 0.80
Toxicity of aerosol propellants in the respiratory and circulatory systems. IV. Cardiotoxicity in the monkey. Toxicology (1974) 0.79
Toxicity of aerosol propellants in the respiratory and circulatory systems V. ventricular function in the dog. Toxicology (1975) 0.79
Intraarterial chemotherapy with limb-sparing resection of large soft-tissue sarcomas of the extremities. J Vasc Interv Radiol (1992) 0.78
Comparative bioavailability of doxycycline. Curr Ther Res Clin Exp (1974) 0.78
Soft-tissue complications of intra-arterial chemotherapy for extremity sarcomas. Ann Plast Surg (1998) 0.77
Prevention of acute pulmonary insufficiency by eriodictyol. J Pharmacol Exp Ther (1974) 0.77
Mutagenicity of metronidazole: structure-activity relationships. Mutat Res (1976) 0.76
Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Invest (1983) 0.76
Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256). Cancer Chemother Rep (1971) 0.76
A potentially toxic drug interaction between pethidine (meperidine) and phenobarbitone. Lancet (1977) 0.76
A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 0.76
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease. Neurology (1999) 0.76
Hepatoma and hepatitis-associated antigen. Br Med J (1973) 0.75
Drug interaction: meperidine and chlorpromazine, a toxic combination. J Clin Pharmacol (1981) 0.75
Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung. Cancer Chemother Rep (1971) 0.75
Pharmacokinetics and mechanisms of action of analgesics in clinical pain. J Clin Pharmacol (1982) 0.75
A phase I study of 6-azauridine (NSC-32074) in solid tumors. Cancer Chemother Rep (1969) 0.75
Prevention of stenosis after vaginal reconstruction using interdigitating flaps of skin and mucosa. Ann Plast Surg (1987) 0.75
Transdermal drug delivery systems: a regulatory hybrid. J Biomater Appl (1988) 0.75
Phase I studies of porfiromycin (NSC--56410) in solid tumors. J Surg Oncol (1975) 0.75
Phase II study of dibromodulcitol (NSC-104800). Cancer Chemother Rep (1975) 0.75
Response to treatment of systemic cryptococcosis in a patient with advanced malignancy: a case report. Del Med J (1982) 0.75
Newer concepts in pain therapy by applied pharmacology of the analgesics. Del Med J (1981) 0.75
Psychologic adjustment of patients with myelopathy. Arch Phys Med Rehabil (1966) 0.75
GLC determination of meperidinic and normeperidinic acids in urine. J Pharm Sci (1978) 0.75
A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2. Oncology (1975) 0.75
Phase I study of dibromodulcitol (NSC-104800). Cancer Chemother Rep (1971) 0.75
Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain. J Clin Pharmacol (1980) 0.75
Phase II study of carbestrol (NSC-19962) in patients with solid tumors. Cancer Chemother Rep (1972) 0.75
The unmotivated patient. Arch Phys Med Rehabil (1968) 0.75
Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease. Cancer Chemother Rep (1970) 0.75
Phase I study of L-asparaginase (NSC 109229). Oncology (1975) 0.75
Sensitive assay for determination of hydroxyzine in plasma and its human pharmacokinetics. J Pharm Sci (1979) 0.75
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors. Oncology (1974) 0.75
Phase II study of azotomycin (NSC-56654). Cancer Chemother Rep (1968) 0.75
Analgesic efficacy of zomepirac sodium in patients with pain due to cancer. J Clin Pharmacol (1982) 0.75
The effect of phenobarbital on the metabolism of meperidine in normal volunteers. J Clin Pharmacol (1978) 0.75
Therapeutic equivalency of two lidocaine preparations. Am J Hosp Pharm (1976) 0.75
Reluctant patient. Special problems in psychologic treatment of patient with myelopathy. N Y State J Med (1968) 0.75
The mechanism of "nicotine reversal" in phenoxybenzamine-treated dogs. J Pharmacol Exp Ther (1968) 0.75
The management of the patient with chronic pain due to advanced malignancy. J Med (1982) 0.75
Illness guilt, inadequacy guilt and rehabilitation therapy. Psychoanal Rev (1968) 0.75
Fate of streptozotocin (NSC-85998)in patients with advanced cancer. Cancer Chemother Rep (1976) 0.75
Murine studies with 5-fluorouracil and leucovorin. J Natl Cancer Inst (1989) 0.75
The bioavailability of meperidine using urine assays for meperidine and normeperidine. J Clin Pharmacol (1975) 0.75
Effect of food on the absorption of eptastigmine. Eur J Clin Pharmacol (1998) 0.75
An improved method for isolating Ca2+-resistant myocytes from the adult rat heart. Res Commun Chem Pathol Pharmacol (1988) 0.75
Ectopic production of ACTH by a primary adenocarcinoma of the colon. J Med Soc N J (1978) 0.75
The bioavailability of meperidine. J Clin Pharmacol (1974) 0.75